Results 51 to 60 of about 1,837,020 (236)
AIDS Medicine and Miracles : v.5:no.1(1995)
, 1995 This issue of AIDS Medicine & Miracles discusses the achievements of Steven Abbott, founder of the Stop AIDS Project. Sam Gallegos is also featured in an article that discusses her activism in the fight against AIDS. Also mentioned is the new director of
core
AIDS Medicine and Miracles : v.6:no.1(1996)
, 1996 This issue of AIDS Medicine & Miracles features Phil Wilson, a Board Member of the non-profit, and discusses his contributions to the HIV/AIDS community as a black, gay man.
core
, 2009 Contains Incident, Prevalent, and Cumulative AIDS Cases in Kansas as of ... by Date of Report "HIV/AIDS and STD Semiannual Report is a publication of the Kansas Department of Health and Environment with funding assistance from the Centers for Disease ...
HIV/AIDS Surveillance Program
core +1 more source
Die behandeling van VIGS - Geneesmiddels en vaksiene - Wat hou die toekoms in?
Koers : Bulletin for Christian Scholarship, 1990 The developing epidemic of acquired immunodeficiency syndrome (AIDS) has prompted a broadly based research effort to find drugs and vaccines for preventing and treating this disease.
C. J. van der Schyf
doaj +1 more source
Creating Markets for New Vaccines Part I: Rationale [PDF]
Malaria, tuberculosis, and the strains of HIV common in Africa kill approximately 5 million people each year. Yet research on vaccines for these diseases remains minimal largely because potential vaccine developers fear that they would not be able to ...
Michael Kremer
core
Experience of initiating collaboration of traditional healers in managing HIV and AIDS in Tanzania [PDF]
, 2007 RefereedCollaboration between traditional healers and biomedical practitioners is now being accepted by many African countries south of the Sahara because of the increasing problem of HIV/AIDS.
Kayombo, E.J +26 more
core +1 more source
Scientific Reports, 2017 As concerns increase about adenovirus type 5 (Ad5) being a safe gene transfer vector, it is important to evaluate its distribution, residence time, and possible toxicity in immunodeficient populations.
Qiang Liu +8 more
doaj +1 more source
Modeling AIDS vaccines: the cellular level
Memorias do Instituto Oswaldo Cruz, 1992 This paper discuses current strategies for the development of AIDS vaccines wich allow immunzation to disturb the natural course of HIV at different detailed stages of its life cycle.
Claudio J. Struchiner +1 more
doaj +1 more source
The Journal of Clinical Investigation, 2023 BACKGROUND Mosaic and consensus HIV-1 immunogens provide two distinct approaches to elicit greater breadth of coverage against globally circulating HIV-1 and have shown improved immunologic breadth in nonhuman primate models.METHODS This double-blind ...
Kristen W. Cohen +30 more
doaj +1 more source
Creating Markets for New Vaccines Part II: Design Issues [PDF]
Several programs have been proposed to improve incentives for research on vaccines for malaria, tuberculosis, and HIV, and to help increase accessibility of vaccines once they are developed.
Michael Kremer
core